BFO
BSX icon

Boston Family Office’s Boston Scientific BSX Stock Holding History

Boston Family Office’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
30,865
+1,241
+4% +$99.3K 0.13% 121
2025
Q4 		$2.83M Buy
29,624
+17,864
+152% +$1.75M 0.18% 102
2025
Q3 		$1.15M Buy
11,760
+174
+2% +$18K 0.07% 155
2025
Q2 		$1.24M Buy
11,586
+87
+0.8% +$8.8K 0.08% 152
2025
Q1 		$1.16M Buy
11,499
+2,805
+32% +$282K 0.08% 148
2024
Q4 		$777K Hold
8,694
– – 0.05% 169
2024
Q3 		$729K Buy
8,694
+250
+3% +$19.7K 0.05% 171
2024
Q2 		$650K Sell
8,444
-100
-1% -$7.32K 0.05% 173
2024
Q1 		$585K Sell
8,544
-500
-6% -$32.1K 0.04% 178
2023
Q4 		$523K Sell
9,044
-168
-2% -$8.97K 0.04% 190
2023
Q3 		$486K Sell
9,212
-300
-3% -$15.7K 0.04% 185
2023
Q2 		$514K Sell
9,512
-55
-0.6% -$2.87K 0.04% 189
2023
Q1 		$478K Sell
9,567
-7,050
-42% -$332K 0.04% 194
2022
Q4 		$769K Hold
16,617
– – 0.06% 170
2022
Q3 		$644K Sell
16,617
-202
-1% -$8.1K 0.06% 173
2022
Q2 		$627K Buy
16,819
+1,105
+7% +$45K 0.05% 176
2022
Q1 		$696K Buy
15,714
+4,870
+45% +$211K 0.05% 177
2021
Q4 		$461K Hold
10,844
– – 0.03% 215
2021
Q3 		$471K Sell
10,844
-3,938
-27% -$174K 0.03% 211
2021
Q2 		$632K Sell
14,782
-2,800
-16% -$118K 0.05% 192
2021
Q1 		$692K Sell
17,582
-7,473
-30% -$283K 0.05% 181
2020
Q4 		$901K Sell
25,055
-5,225
-17% -$188K 0.07% 166
2020
Q3 		$1.16M Hold
30,280
– – 0.11% 134
2020
Q2 		$1.06M Hold
30,280
– – 0.1% 139
2020
Q1 		$988K Sell
30,280
-11,000
-27% -$430K 0.12% 131
2019
Q4 		$1.87M Sell
41,280
-1,200
-3% -$50.2K 0.18% 113
2019
Q3 		$1.73M Buy
42,480
+1,075
+3% +$45.5K 0.18% 114
2019
Q2 		$1.78M Buy
41,405
+100
+0.2% +$3.85K 0.18% 114
2019
Q1 		$1.58M Buy
41,305
+1,675
+4% +$64K 0.17% 117
2018
Q4 		$1.4M Buy
39,630
+2,125
+6% +$77.1K 0.17% 119
2018
Q3 		$1.44M Buy
37,505
+280
+0.8% +$9.78K 0.15% 129
2018
Q2 		$1.22M Sell
37,225
-2,675
-7% -$80.7K 0.14% 137
2018
Q1 		$1.09M Sell
39,900
-1,625
-4% -$44.2K 0.12% 145
2017
Q4 		$1.03M Sell
41,525
-2,025
-5% -$55.9K 0.11% 148
2017
Q3 		$1.27M Hold
43,550
– – 0.14% 136
2017
Q2 		$1.21M Hold
43,550
– – 0.14% 140
2017
Q1 		$1.08M Buy
43,550
+1,925
+5% +$46.8K 0.13% 144
2016
Q4 		$900K Buy
41,625
+7,325
+21% +$160K 0.12% 154
2016
Q3 		$816K Buy
34,300
+3,425
+11% +$81.7K 0.11% 159
2016
Q2 		$722K Buy
+30,875
New +$668K 0.09% 162

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Family Office's BSX Position: Q1 2026 in Review

Boston Family Office increased its Boston Scientific (BSX) stake by 4.2% in Q1 2026, buying an estimated $99.3K and bringing the position to 30,865 shares worth $1.94M. The position accounts for 0.13% of the portfolio, ranked #121.

Boston Family Office first reported a position in BSX in Q2 2016 and has held it in 40 quarters since. The position peaked at $2.83M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Boston Family Office held 30,865 shares of Boston Scientific worth $1.94M as of Q1 2026.
  • Boston Family Office bought 1,241 Boston Scientific shares in Q1 2026, an estimated $99.3K.
  • Boston Scientific made up 0.13% of Boston Family Office's portfolio in Q1 2026, its #121 holding.
  • Boston Family Office first reported a position in Boston Scientific in Q2 2016 and has held it in 40 quarters since.
  • Boston Family Office's Boston Scientific position peaked at $2.83M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Boston Family Office's 13F filing for Q1 2026, filed 13 May 2026.